Department of Vascular Surgery, Maastricht University Medical Center, Maastricht, the Netherlands.
Department of Vascular Surgery, Zuyderland Medical Center, Heerlen, the Netherlands.
J Cardiovasc Surg (Torino). 2023 Jun;64(3):268-278. doi: 10.23736/S0021-9509.22.12311-6. Epub 2022 Sep 14.
The impact of stent-graft complexity on clinical outcome after fenestrated endovascular aortic aneurysm repair (FEVAR) has been conflicting in the literature. The objective of this study was to compare mid-term results of stent-grafts with renal fenestrations alone with more complex stent-grafts including mesenteric fenestrations.
A single center retrospective study was conducted on 154 patients, who underwent FEVAR from 2006 to 2020 at our institution.
There were 54 (35.1%) patients in the renal FEVAR group and 100 (64.9%) patients in the complex FEVAR group. Median follow-up of the total group was 25 months (IQR 7-45). There were no significant differences in technical success and perioperative mortality. Intraoperative complications (4% vs. 18%, P=0.001), operative time (145 min vs. 191 min, P=0.001), radiation dose (119372 mGycm vs. 159573 mGycm, P=0.004) and fluoroscopy time (39 min vs. 54 min, P=0.007) were significantly lower in the renal FEVAR group. During follow-up target vessel instability, endoleaks and reinterventions were not significantly different between the two groups.
In this single center retrospective study, renal FEVAR was a safe and effective treatment for patients with juxtarenal AAA demonstrating fewer intraoperative complications and similar mid-term outcomes as complex FEVAR. If the anatomy is compatible for renal FEVAR, it might be unnecessary to expose patients to potentially more complications by choosing a complex FEVAR strategy.
在血管腔内修复术治疗主动脉瘤(EVAR)中,覆膜支架开窗的复杂性对临床结果的影响在文献中存在争议。本研究旨在比较单纯肾动脉开窗支架和包括肠系膜开窗支架在内的更复杂支架的中期结果。
回顾性分析了 2006 年至 2020 年在我院接受 EVAR 的 154 例患者的临床资料。
单纯肾动脉开窗组(FEVAR 组)54 例(35.1%),复杂 FEVAR 组 100 例(64.9%)。全组中位随访时间为 25 个月(IQR 7-45)。两组技术成功率和围手术期死亡率无显著差异。术中并发症(4% vs. 18%,P=0.001)、手术时间(145 min vs. 191 min,P=0.001)、辐射剂量(119372 mGycm vs. 159573 mGycm,P=0.004)和透视时间(39 min vs. 54 min,P=0.007)均显著降低。在随访期间,两组间靶血管不稳定、内漏和再干预无显著差异。
在本单中心回顾性研究中,对于肾旁 AAA 患者,单纯肾动脉开窗 EVAR 是一种安全有效的治疗方法,术中并发症较少,中期结果与复杂 EVAR 相似。如果解剖结构适合单纯肾动脉开窗 EVAR,那么选择复杂 EVAR 策略可能会使患者面临更多潜在并发症。